Citation 20232

POETSCH,M: ZAHNER,H: WERNER,RG: KERN,A: JUNG,G:. (1985). METABOLIC PRODUCTS FROM MICROORGANISMS. 230. AMICLENOMYCIN-PEPTIDES, NEW ANTIMETABOLITES OF BIOTIN. TAXONOMY, FERMENTATION AND BIOLOGICAL PROPERTIES.. 38(3)

Citation Details

Title	METABOLIC PRODUCTS FROM MICROORGANISMS. 230. AMICLENOMYCIN-PEPTIDES, NEW ANTIMETABOLITES OF BIOTIN. TAXONOMY, FERMENTATION AND BIOLOGICAL PROPERTIES.
Authors	POETSCH,M: ZAHNER,H: WERNER,RG: KERN,A: JUNG,G:
Year	1985
Volume	38
Issue	3

Summary

Year: 1985

Journal: Unknown

Organisms and Their Experiments (1)

Streptomyces venezuelae (STREPTOMYCETACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	AMICLENOMYCIN,L: L-ISO-LEUCYL:	None
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN,L: L-ISO-LEUCYL:	ACTIVE
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN,L: L-ISO-LEUCYL:	INACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN,L: L-ISO-LEUCYL:	ACTIVE
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN,L: L-ISO-LEUCYL:	ACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN,L: L-ISO-LEUCYL:	ACTIVE
7	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN,L: L-ISO-LEUCYL:	ACTIVE
8	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN,L: L-ISO-LEUCYL:	ACTIVE
9	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN,L: L-ISO-LEUCYL:	INACTIVE
10	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VITRO	AMICLENOMYCIN,L: L-ISO-LEUCYL:	INACTIVE
11	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STRAVIDIN	None
12	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STRAVIDIN	ACTIVE
13	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STRAVIDIN	ACTIVE
14	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STRAVIDIN	ACTIVE
15	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STRAVIDIN	ACTIVE
16	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STRAVIDIN	INACTIVE
17	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STRAVIDIN	ACTIVE
18	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STRAVIDIN	ACTIVE
19	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STRAVIDIN	WEAK ACTIVITY
20	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VITRO	STRAVIDIN	INACTIVE
21	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STREPTOMYCES ANTIBIOTIC MSD-235-S-2	None
22	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOMYCES ANTIBIOTIC MSD-235-S-2	ACTIVE
23	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOMYCES ANTIBIOTIC MSD-235-S-2	INACTIVE
24	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOMYCES ANTIBIOTIC MSD-235-S-2	ACTIVE
25	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOMYCES ANTIBIOTIC MSD-235-S-2	ACTIVE
26	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOMYCES ANTIBIOTIC MSD-235-S-2	ACTIVE
27	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOMYCES ANTIBIOTIC MSD-235-S-2	ACTIVE
28	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOMYCES ANTIBIOTIC MSD-235-S-2	ACTIVE
29	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOMYCES ANTIBIOTIC MSD-235-S-2	WEAK ACTIVITY
30	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC MSD-235-S-2	INACTIVE
31	Not specified	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	AMICLENOMYCIN-L-GLUTAMINE,L: L-METHYL-ISO-LEUCYL:	None
32	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-METHYL-ISO-LEUCYL:	ACTIVE
33	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-METHYL-ISO-LEUCYL:	ACTIVE
34	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-METHYL-ISO-LEUCYL:	ACTIVE
35	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-METHYL-ISO-LEUCYL:	ACTIVE
36	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-METHYL-ISO-LEUCYL:	WEAK ACTIVITY
37	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-METHYL-ISO-LEUCYL:	ACTIVE
38	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-METHYL-ISO-LEUCYL:	ACTIVE
39	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-METHYL-ISO-LEUCYL:	ACTIVE
40	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VITRO	AMICLENOMYCIN-L-GLUTAMINE,L: L-METHYL-ISO-LEUCYL:AMICLENOMYCIN-L-GLUTAMINE,L: L-ISOLEUCYL:	INACTIVE
41	Not specified	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	AMICLENOMYCIN-L-GLUTAMINE,L: L-ISOLEUCYL:	None
42	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-ISOLEUCYL:	ACTIVE
43	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-ISOLEUCYL:	ACTIVE
44	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-ISOLEUCYL:	None
45	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-ISOLEUCYL:	ACTIVE
46	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-ISOLEUCYL:	ACTIVE
47	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-ISOLEUCYL:	ACTIVE
48	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-ISOLEUCYL:	ACTIVE
49	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE,L: L-ISOLEUCYL:	ACTIVE
50	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VITRO	AMICLENOMYCIN-L-GLUTAMINE,L: L-ISOLEUCYL:	INACTIVE
51	Not specified	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	AMICLENOMYCIN-L-GLUTAMINE, L: L-VALYL:	None
52	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE, L: L-VALYL:	ACTIVE
53	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE, L: L-VALYL:	ACTIVE
54	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE, L: L-VALYL:	ACTIVE
55	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE, L: L-VALYL:	ACTIVE
56	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE, L: L-VALYL:	ACTIVE
57	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE, L: L-VALYL:	ACTIVE
58	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE, L: L-VALYL:	ACTIVE
59	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMICLENOMYCIN-L-GLUTAMINE, L: L-VALYL:	ACTIVE
60	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VITRO	AMICLENOMYCIN-L-GLUTAMINE, L: L-VALYL:	INACTIVE

Citation 20232

Citation Details

Summary

Organisms and Their Experiments (1)

Streptomyces venezuelae (STREPTOMYCETACEAE)

Show SPARQL Queries (1)

Query 1